Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Hwai Wen Chang0

Arlene Helen Sharpe0

Gordon James Freeman0

Jennifer Marie Mataraza0

Catherine Anne Sabatos-Peyton0

Walter A. Blattler0

Gerhard Johann Frey0

Date of Patent

November 28, 2023

0

Patent Application Number

169259800

Date Filed

July 10, 2020

0

Patent Citations

US Patent 9505839 Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

0

US Patent 9815898 Antibody molecules to PD-1 and uses thereof

0

US Patent 9815901 Treatment of cancer using a CD123 chimeric antigen receptor

0

US Patent 9834605 Antibodies to human programmed death receptor PD-1

0

US Patent 9884913 Antibody molecules to TIM-3 and uses thereof

0

US Patent 9908936 Antibody molecules to LAG-3 and uses thereof

0

US Patent 9944645 Imidazotriazines and imidazopyrimidines as kinase inhibitors

0

US Patent 9988452 Antibody molecules to PD-L1 and uses thereof

0

...

Patent Primary Examiner

Jessica H Roark

0

CPC Code

0

0

0

0

0

0

0

Patent abstract

Antibody molecules that specifically bind to PD-1 are disclosed. The anti-PD-1 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious conditions and disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11827704 Antibody molecules to PD-1 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool